Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer.
Onishi H, Shioyama Y, Matsumoto Y, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nakata K, Takeda A, Uno T, Nomiya T, Taguchi H, Seo Y, Komiyama T, Marino K, Aoki S, Matsuda M, Akita T, Saito M. Onishi H, et al. Among authors: takeda a. Cancers (Basel). 2023 Sep 1;15(17):4382. doi: 10.3390/cancers15174382. Cancers (Basel). 2023. PMID: 37686657 Free PMC article.
Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database.
Shioyama Y, Onishi H, Takayama K, Matsuo Y, Takeda A, Yamashita H, Miyakawa A, Murakami N, Aoki M, Matsushita H, Matsumoto Y, Shibamoto Y; Japanese Radiological Society Multi-Institutional SBRT Study Group (JRS-SBRTSG). Shioyama Y, et al. Among authors: takeda a. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818783904. doi: 10.1177/1533033818783904. Technol Cancer Res Treat. 2018. PMID: 29983096 Free PMC article.
Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study.
Onishi H, Yamashita H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, Miyakawa A, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nakata K, Takeda A, Uno T, Nomiya T, Takanaka T, Seo Y, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehata Y, Tominaga L, Kuriyama K. Onishi H, et al. Among authors: takeda a. Cancers (Basel). 2018 Aug 2;10(8):257. doi: 10.3390/cancers10080257. Cancers (Basel). 2018. PMID: 30072613 Free PMC article.
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, Yamada K, Araki T. Onishi H, et al. Among authors: takeda a. J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S94-100. doi: 10.1097/JTO.0b013e318074de34. J Thorac Oncol. 2007. PMID: 17603311 Free article.
Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination.
Inoue T, Shimizu S, Onimaru R, Takeda A, Onishi H, Nagata Y, Kimura T, Karasawa K, Arimoto T, Hareyama M, Kikuchi E, Shirato H. Inoue T, et al. Among authors: takeda a. Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):683-7. doi: 10.1016/j.ijrobp.2008.11.026. Epub 2009 Feb 21. Int J Radiat Oncol Biol Phys. 2009. PMID: 19231107
Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.
Eriguchi T, Takeda A, Oku Y, Ishikura S, Kimura T, Ozawa S, Nakashima T, Matsuo Y, Nakamura M, Matsumoto Y, Yamazaki S, Sanuki N, Ito Y. Eriguchi T, et al. Among authors: takeda a. Radiat Oncol. 2013 May 4;8:113. doi: 10.1186/1748-717X-8-113. Radiat Oncol. 2013. PMID: 23641879 Free PMC article.
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T. Onishi H, et al. Among authors: takeda a. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. doi: 10.1016/j.ijrobp.2009.07.1751. Epub 2010 Jul 16. Int J Radiat Oncol Biol Phys. 2011. PMID: 20638194
Impact of Local Recurrence on Cause-Specific Death After Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Dynamic Prediction Using Landmark Model.
Ueki K, Matsuo Y, Takeda A, Morita S, Taguri M, Kishi N, Hanazawa H, Tsurugai Y, Mizowaki T. Ueki K, et al. Among authors: takeda a. Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1135-1143. doi: 10.1016/j.ijrobp.2021.11.025. Epub 2021 Nov 26. Int J Radiat Oncol Biol Phys. 2022. PMID: 34838867
In Reply to Li et al.
Kimura T, Takeda A, Tsurugai Y. Kimura T, et al. Among authors: takeda a. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):616-617. doi: 10.1016/j.ijrobp.2020.12.054. Int J Radiat Oncol Biol Phys. 2021. PMID: 33989585 No abstract available.
2,130 results